Table 2. The severity and screening for anxiety disorder.
| Self-reported anxiety disorder severity |
Screening for anxiety disorder | P-value | |||||
|---|---|---|---|---|---|---|---|
| None | Mild | Moderate | Severe | Negative | Positive | ||
| Number of participants | 1160 | 308 | 85 | 30 | 1468 | 115 | |
|
%
(95% C.I.) |
73.3
(71.0–75.4) |
19.5
(17.6–21.5) |
5.4
(4.4–6.6) |
1.9
(1.3–2.7) |
92.7
(91.3–93.9) |
7.3
(6.0–8.7) |
|
| Demographic factors | |||||||
| Gender, n(%) | <0.001 a | ||||||
| Female | 739 (74.6) | 199 (20.1) | 39 (3.9) | 14 (1.4) | 938 (94.7) | 53 (5.3) | |
| Male | 421 (71.1) | 109 (18.4) | 46 (7.8) | 16 (2.7) | 530 (89.5) | 62 (10.5) | |
| Marital status, n(%) | 0.208b | ||||||
| Single | 1152 (73.3) | 306 (19.5) | 85 (5.4) | 28 (1.8) | 1458 (92.8) | 113 (7.2) | |
| Other | 8 (66.7) | 2 (16.7) | 0 (0.0) | 2 (16.7) | 10 (83.3) | 2 (16.7) | |
| Having difficulty in paying for healthcare service, n(%) | <0.001 a | ||||||
| No | 662 (80.4) | 122 (14.8) | 32 (3.9) | 7 (0.9) | 784 (95.3) | 39 (4.7) | |
| Yes | 498 (65.5) | 186 (24.5) | 53 (7.0) | 23 (3.0) | 684 (90.0) | 76 (10.0) | |
| Academic factors | |||||||
| Academic major, n(%) | 0.252a | ||||||
| Doctor of General Medicine | 747 (72.4) | 203 (19.7) | 64 (6.2) | 18 (1.7) | 950 (92.1) | 82 (7.9) | |
| Doctor of Preventive Medicine | 228 (74.0) | 59 (19.2) | 15 (4.9) | 6 (1.9) | 287 (93.2) | 21 (6.8) | |
| Bachelor of Nursing | 185 (76.1) | 46 (18.9) | 6 (2.5) | 6 (2.5) | 231 (95.1) | 12 (4.9) | |
| Having clinical experience, n(%) | 0.394a | ||||||
| No | 396 (72.3) | 108 (19.7) | 31 (5.7) | 13 (2.4) | 504 (92.0) | 44 (8.0) | |
| Yes | 764 (73.8) | 200 (19.3) | 54 (5.2) | 17 (1.6) | 964 (93.1) | 71 (6.9) | |
| Health factors, n(%) | |||||||
| BMI classification, n(%) | 0.126a | ||||||
| Underweight | 224 (69.6) | 74 (23.0) | 16 (5.0) | 8 (2.5) | 298 (92.5) | 24 (7.5) | |
| Normal | 760 (74.1) | 195 (19.0) | 52 (5.1) | 19 (1.9) | 955 (93.1) | 71 (6.9) | |
| Overweight | 157 (75.1) | 37 (17.7) | 12 (5.7) | 3 (1.4) | 194 (92.8) | 15 (7.2) | |
| Obese | 19 (73.1) | 2 (7.7) | 5 (19.2) | 0 (0.0) | 21 (80.8) | 5 (19.2) | |
| COVID-19 symptoms, n(%) | 0.355a | ||||||
| Has no symptoms | 965 (75.6) | 224 (17.5) | 65 (5.1) | 23 (1.8) | 1189 (93.1) | 88 (6.9) | |
| Has only atypical symptoms | 157 (64.3) | 67 (27.5) | 18 (7.4) | 2 (0.8) | 224 (91.8) | 20 (8.2) | |
| Has at least one typical symptom | 38 (61.3) | 17 (27.4) | 2 (3.2) | 5 (8.1) | 55 (88.7) | 7 (11.3) | |
| Having chronic diseases, n(%) | 0.539a | ||||||
| No | 1081 (73.6) | 282 (19.2) | 77 (5.2) | 28 (1.9) | 1363 (92.8) | 105 (7.2) | |
| Yes | 79 (68.7) | 26 (22.6) | 8 (7.0) | 2 (1.7) | 105 (91.3) | 10 (8.7) | |
| Fear of COVID-19, n(%) | <0.001 a | ||||||
| Q1 | 350 (81.4) | 64 (14.9) | 11 (2.6) | 5 (1.2) | 414 (96.3) | 16 (3.7) | |
| Q2 | 294 (77.2) | 71 (18.6) | 14 (3.7) | 2 (0.5) | 365 (95.8) | 16 (4.2) | |
| Q3 | 420 (68.6) | 137 (22.4) | 44 (7.2) | 11 (1.8) | 557 (91.0) | 55 (9.0) | |
| Q4 | 96 (60.0) | 36 (22.5) | 16 (10.0) | 12 (7.5) | 132 (82.5) | 28 (17.5) | |
Statistical comparison between screened negative and positive using.
a Chi-square test for categorical variable—display as n(%).
b Fisher-exact test for categorical variable—display as n(%).
The bold p-value indicated statistical significance (p<0.05).
BMI: Body Mass Index, COVID-19: Coronavirus Disease of 2019, the FCoV-19S score was divided into four groups based on quartiles: Q1, Q2, Q3, and Q4. Q1 group contained 25% participants with the lowest score from 7 to 13 points; Q2 group consisted of 25% participants with medium low score from 14 to 20 points; Q3 group was 25% participants with medium high score from 21 to 27 points; Q4 group was 25% participants with highest score from 28 to 35 points.